LeafNLP Demos
Back to explore

Report #2865222

Received Oct 13, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
NY
Recovered
Unknown
Vaccinated
Oct 8, 2025
Onset
Oct 8, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS2UNK—

Symptoms (1)

Inappropriate schedule of product administration

Symptom narrative

got shot 1 of Shingrix on an unspecified date in October 2024 and shot 2 on 08-OCT-2025 today on the day of reporting; This non-serious case was reported by a consumer via call center representative and described the occurrence of drug dose administration interval too long in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (1st dose received in OCT-2024). On 08-OCT-2025, the patient received the 2nd dose of Shingrix. On 08-OCT-2025, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: got shot 1 of Shingrix on an unspecified date in October 2024 and shot 2 on 08-OCT-2025 today on the day of reporting). The outcome of the drug dose administration interval too long was not applicable. Additional Information: GSK Receipt Date: 08-OCT-2025 The patient self-reported this case for herself. The batch number was not provided, and unable to contact the reporter.